About Temsirolimus (concentrate)
Class: | Antineoplastic agent; mTOR inhibitor
Use: | Treatment of advanced renal cell carcinoma (RCC) and certain other malignancies
Adult dose: | 25 mg administered intravenously once weekly; may be adjusted based on tolerance and toxicity
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Common side effects include fatigue, nausea, diarrhea, mucositis, rash, and elevated liver enzymes
Contraindications: | Hypersensitivity to temsirolimus or a
Drug Class
Antineoplastic agent; mTOR inhibitor
Uses & Indications
Treatment of advanced renal cell carcinoma (RCC) and certain other malignancies
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from light; do not freeze
Manufacturer & Packaging
Manufacturer: Wyeth Lederle S.p.A., ITALY
Package Size
1 Vial (1.2ml Concentrate) + 1 Diluent Vial (1.8ml)
Price & Supplier
Price in UAE: AED 5458.50
Dosage Information
Adult Dose
25 mg administered intravenously once weekly; may be adjusted based on tolerance and toxicity
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Common side effects include fatigue, nausea, diarrhea, mucositis, rash, and elevated liver enzymes
Contraindications & Precautions
Hypersensitivity to temsirolimus or any component of the formulation; concurrent use with strong CYP3A4 inhibitors
Important Warnings
Risk of serious infections, hypersensitivity reactions, and renal toxicity; monitor for signs of infection and renal function during treatment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.